nodes	percent_of_prediction	percent_of_DWPC	metapath
Mebendazole—CYP1A1—prostate cancer	0.181	0.61	CbGaD
Mebendazole—TUBB4B—Cabazitaxel—prostate cancer	0.177	0.329	CbGbCtD
Mebendazole—CYP3A4—prostate cancer	0.116	0.39	CbGaD
Mebendazole—TUBB4B—Docetaxel—prostate cancer	0.0594	0.11	CbGbCtD
Mebendazole—CYP1A1—Flutamide—prostate cancer	0.0436	0.081	CbGbCtD
Mebendazole—CYP1A1—Estrone—prostate cancer	0.0316	0.0585	CbGbCtD
Mebendazole—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0235	0.0435	CbGbCtD
Mebendazole—ABCB1—Estramustine—prostate cancer	0.0191	0.0355	CbGbCtD
Mebendazole—CYP1A1—Estradiol—prostate cancer	0.0181	0.0336	CbGbCtD
Mebendazole—ABCB1—Cabazitaxel—prostate cancer	0.0126	0.0234	CbGbCtD
Mebendazole—CYP3A4—Bicalutamide—prostate cancer	0.0123	0.0229	CbGbCtD
Mebendazole—ABCB1—Estrone—prostate cancer	0.0123	0.0229	CbGbCtD
Mebendazole—CYP3A4—Estramustine—prostate cancer	0.0115	0.0213	CbGbCtD
Mebendazole—ABCB1—Ethinyl Estradiol—prostate cancer	0.011	0.0204	CbGbCtD
Mebendazole—CYP3A4—Flutamide—prostate cancer	0.0102	0.019	CbGbCtD
Mebendazole—CYP3A4—Abiraterone—prostate cancer	0.0102	0.019	CbGbCtD
Mebendazole—ABCB1—Conjugated Estrogens—prostate cancer	0.00806	0.015	CbGbCtD
Mebendazole—CYP3A4—Cabazitaxel—prostate cancer	0.00756	0.014	CbGbCtD
Mebendazole—CYP3A4—Estrone—prostate cancer	0.00739	0.0137	CbGbCtD
Mebendazole—ABCB1—Mitoxantrone—prostate cancer	0.00733	0.0136	CbGbCtD
Mebendazole—ABCB1—Estradiol—prostate cancer	0.00708	0.0131	CbGbCtD
Mebendazole—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00658	0.0122	CbGbCtD
Mebendazole—ABCB1—Prednisone—prostate cancer	0.00609	0.0113	CbGbCtD
Mebendazole—CYP3A4—Conjugated Estrogens—prostate cancer	0.00483	0.00896	CbGbCtD
Mebendazole—ABCB1—Etoposide—prostate cancer	0.00462	0.00858	CbGbCtD
Mebendazole—CYP3A4—Mitoxantrone—prostate cancer	0.00439	0.00815	CbGbCtD
Mebendazole—CYP3A4—Estradiol—prostate cancer	0.00424	0.00787	CbGbCtD
Mebendazole—ABCB1—Docetaxel—prostate cancer	0.00423	0.00785	CbGbCtD
Mebendazole—CYP3A4—Prednisone—prostate cancer	0.00365	0.00677	CbGbCtD
Mebendazole—ABCB1—Doxorubicin—prostate cancer	0.00315	0.00585	CbGbCtD
Mebendazole—CYP3A4—Etoposide—prostate cancer	0.00277	0.00514	CbGbCtD
Mebendazole—TUBA1A—prostate gland—prostate cancer	0.00256	0.0906	CbGeAlD
Mebendazole—CYP3A4—Docetaxel—prostate cancer	0.00253	0.0047	CbGbCtD
Mebendazole—TUBA1A—seminal vesicle—prostate cancer	0.00217	0.0766	CbGeAlD
Mebendazole—CYP3A4—urine—prostate cancer	0.00196	0.0691	CbGeAlD
Mebendazole—CYP3A4—Doxorubicin—prostate cancer	0.00189	0.0035	CbGbCtD
Mebendazole—TUBA1A—epithelium—prostate cancer	0.00188	0.0665	CbGeAlD
Mebendazole—TUBA1A—renal system—prostate cancer	0.00175	0.0617	CbGeAlD
Mebendazole—TUBA1A—urethra—prostate cancer	0.00172	0.0606	CbGeAlD
Mebendazole—TUBB4B—prostate gland—prostate cancer	0.00171	0.0604	CbGeAlD
Mebendazole—Menorrhagia—Ethinyl Estradiol—prostate cancer	0.00154	0.0349	CcSEcCtD
Mebendazole—TUBB4B—seminal vesicle—prostate cancer	0.00145	0.0511	CbGeAlD
Mebendazole—TUBA1A—bone marrow—prostate cancer	0.00132	0.0467	CbGeAlD
Mebendazole—Menorrhagia—Goserelin—prostate cancer	0.00127	0.0287	CcSEcCtD
Mebendazole—TUBB4B—renal system—prostate cancer	0.00116	0.0411	CbGeAlD
Mebendazole—TUBB4B—urethra—prostate cancer	0.00114	0.0404	CbGeAlD
Mebendazole—TUBA1A—testis—prostate cancer	0.00113	0.0399	CbGeAlD
Mebendazole—Menorrhagia—Estradiol—prostate cancer	0.001	0.0227	CcSEcCtD
Mebendazole—Menorrhagia—Mitoxantrone—prostate cancer	0.000935	0.0212	CcSEcCtD
Mebendazole—Hepatitis—Flutamide—prostate cancer	0.000933	0.0211	CcSEcCtD
Mebendazole—Neutropenia—Cabazitaxel—prostate cancer	0.000921	0.0209	CcSEcCtD
Mebendazole—TUBB4B—bone marrow—prostate cancer	0.000881	0.0311	CbGeAlD
Mebendazole—TUBA1A—lymph node—prostate cancer	0.000819	0.0289	CbGeAlD
Mebendazole—Angioedema—Estrone—prostate cancer	0.000803	0.0182	CcSEcCtD
Mebendazole—Neutropenia—Bicalutamide—prostate cancer	0.00079	0.0179	CcSEcCtD
Mebendazole—TUBB4B—testis—prostate cancer	0.000753	0.0266	CbGeAlD
Mebendazole—CYP1A1—epithelium—prostate cancer	0.000703	0.0248	CbGeAlD
Mebendazole—Angioedema—Estradiol valerate/Dienogest—prostate cancer	0.000701	0.0159	CcSEcCtD
Mebendazole—CYP1A1—renal system—prostate cancer	0.000652	0.023	CbGeAlD
Mebendazole—CYP1A1—urethra—prostate cancer	0.000641	0.0226	CbGeAlD
Mebendazole—Albendazole—CYP1A1—prostate cancer	0.000624	0.264	CrCbGaD
Mebendazole—Urticaria—Estrone—prostate cancer	0.00057	0.0129	CcSEcCtD
Mebendazole—Abdominal pain—Estrone—prostate cancer	0.000567	0.0128	CcSEcCtD
Mebendazole—TUBB4B—lymph node—prostate cancer	0.000546	0.0193	CbGeAlD
Mebendazole—Gastrointestinal pain—Nilutamide—prostate cancer	0.000545	0.0123	CcSEcCtD
Mebendazole—Angioedema—Bicalutamide—prostate cancer	0.000538	0.0122	CcSEcCtD
Mebendazole—Abdominal pain—Nilutamide—prostate cancer	0.000526	0.0119	CcSEcCtD
Mebendazole—Gastrointestinal pain—Estradiol valerate/Dienogest—prostate cancer	0.000512	0.0116	CcSEcCtD
Mebendazole—Urticaria—Estradiol valerate/Dienogest—prostate cancer	0.000497	0.0113	CcSEcCtD
Mebendazole—ABCB1—prostate gland—prostate cancer	0.000497	0.0176	CbGeAlD
Mebendazole—Abdominal pain—Estradiol valerate/Dienogest—prostate cancer	0.000495	0.0112	CcSEcCtD
Mebendazole—Gastrointestinal pain—Degarelix—prostate cancer	0.000486	0.011	CcSEcCtD
Mebendazole—CYP3A4—renal system—prostate cancer	0.000479	0.0169	CbGeAlD
Mebendazole—Rash—Estramustine—prostate cancer	0.000473	0.0107	CcSEcCtD
Mebendazole—Dermatitis—Estramustine—prostate cancer	0.000473	0.0107	CcSEcCtD
Mebendazole—Urticaria—Degarelix—prostate cancer	0.000473	0.0107	CcSEcCtD
Mebendazole—Hepatitis—Goserelin—prostate cancer	0.000471	0.0107	CcSEcCtD
Mebendazole—Abdominal pain—Degarelix—prostate cancer	0.00047	0.0107	CcSEcCtD
Mebendazole—Hypersensitivity—Estradiol valerate/Dienogest—prostate cancer	0.000461	0.0104	CcSEcCtD
Mebendazole—Rash—Abiraterone—prostate cancer	0.00046	0.0104	CcSEcCtD
Mebendazole—Dermatitis—Abiraterone—prostate cancer	0.000459	0.0104	CcSEcCtD
Mebendazole—Gastrointestinal pain—Cabazitaxel—prostate cancer	0.000458	0.0104	CcSEcCtD
Mebendazole—Angioedema—Ethinyl Estradiol—prostate cancer	0.000455	0.0103	CcSEcCtD
Mebendazole—Rash—Estrone—prostate cancer	0.000452	0.0102	CcSEcCtD
Mebendazole—Dermatitis—Estrone—prostate cancer	0.000452	0.0102	CcSEcCtD
Mebendazole—Abdominal pain—Cabazitaxel—prostate cancer	0.000443	0.01	CcSEcCtD
Mebendazole—Hypersensitivity—Degarelix—prostate cancer	0.000438	0.00993	CcSEcCtD
Mebendazole—ABCB1—seminal vesicle—prostate cancer	0.00042	0.0148	CbGeAlD
Mebendazole—Rash—Nilutamide—prostate cancer	0.00042	0.00951	CcSEcCtD
Mebendazole—Dermatitis—Nilutamide—prostate cancer	0.000419	0.00951	CcSEcCtD
Mebendazole—Rash—Flutamide—prostate cancer	0.000418	0.00947	CcSEcCtD
Mebendazole—Dermatitis—Flutamide—prostate cancer	0.000418	0.00946	CcSEcCtD
Mebendazole—Hypersensitivity—Cabazitaxel—prostate cancer	0.000413	0.00936	CcSEcCtD
Mebendazole—Neutropenia—Mitoxantrone—prostate cancer	0.000406	0.0092	CcSEcCtD
Mebendazole—Albendazole—CYP3A4—prostate cancer	0.000398	0.168	CrCbGaD
Mebendazole—Rash—Estradiol valerate/Dienogest—prostate cancer	0.000395	0.00894	CcSEcCtD
Mebendazole—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.000394	0.00893	CcSEcCtD
Mebendazole—Gastrointestinal pain—Bicalutamide—prostate cancer	0.000393	0.00891	CcSEcCtD
Mebendazole—Urticaria—Bicalutamide—prostate cancer	0.000382	0.00865	CcSEcCtD
Mebendazole—Abdominal pain—Bicalutamide—prostate cancer	0.00038	0.00861	CcSEcCtD
Mebendazole—Rash—Degarelix—prostate cancer	0.000375	0.0085	CcSEcCtD
Mebendazole—Dermatitis—Degarelix—prostate cancer	0.000375	0.00849	CcSEcCtD
Mebendazole—Hepatitis—Estradiol—prostate cancer	0.000373	0.00846	CcSEcCtD
Mebendazole—Angioedema—Conjugated Estrogens—prostate cancer	0.000371	0.0084	CcSEcCtD
Mebendazole—ABCB1—epithelium—prostate cancer	0.000365	0.0129	CbGeAlD
Mebendazole—Agranulocytosis—Mitoxantrone—prostate cancer	0.000361	0.00819	CcSEcCtD
Mebendazole—Convulsion—Goserelin—prostate cancer	0.000355	0.00805	CcSEcCtD
Mebendazole—Hypersensitivity—Bicalutamide—prostate cancer	0.000354	0.00803	CcSEcCtD
Mebendazole—Convulsion—Conjugated Estrogens—prostate cancer	0.000352	0.00797	CcSEcCtD
Mebendazole—Hepatitis—Mitoxantrone—prostate cancer	0.000348	0.00788	CcSEcCtD
Mebendazole—Bopindolol—ADRB2—prostate cancer	0.000341	0.144	CrCbGaD
Mebendazole—ABCB1—renal system—prostate cancer	0.000339	0.012	CbGeAlD
Mebendazole—Neutropenia—Etoposide—prostate cancer	0.000338	0.00766	CcSEcCtD
Mebendazole—ABCB1—urethra—prostate cancer	0.000333	0.0118	CbGeAlD
Mebendazole—Gastrointestinal pain—Ethinyl Estradiol—prostate cancer	0.000332	0.00753	CcSEcCtD
Mebendazole—Urticaria—Ethinyl Estradiol—prostate cancer	0.000323	0.00732	CcSEcCtD
Mebendazole—Abdominal pain—Ethinyl Estradiol—prostate cancer	0.000321	0.00728	CcSEcCtD
Mebendazole—CYP1A1—lymph node—prostate cancer	0.000306	0.0108	CbGeAlD
Mebendazole—Rash—Bicalutamide—prostate cancer	0.000303	0.00687	CcSEcCtD
Mebendazole—Dermatitis—Bicalutamide—prostate cancer	0.000303	0.00686	CcSEcCtD
Mebendazole—Agranulocytosis—Etoposide—prostate cancer	0.000301	0.00681	CcSEcCtD
Mebendazole—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.000299	0.00678	CcSEcCtD
Mebendazole—Angioedema—Estradiol—prostate cancer	0.000297	0.00673	CcSEcCtD
Mebendazole—Neutropenia—Docetaxel—prostate cancer	0.000281	0.00636	CcSEcCtD
Mebendazole—Gastrointestinal pain—Goserelin—prostate cancer	0.000273	0.0062	CcSEcCtD
Mebendazole—Neutropenia—Capecitabine—prostate cancer	0.000272	0.00616	CcSEcCtD
Mebendazole—Gastrointestinal pain—Conjugated Estrogens—prostate cancer	0.000271	0.00614	CcSEcCtD
Mebendazole—Ketoprofen—CXCL8—prostate cancer	0.000271	0.115	CrCbGaD
Mebendazole—Urticaria—Goserelin—prostate cancer	0.000266	0.00602	CcSEcCtD
Mebendazole—Abdominal pain—Goserelin—prostate cancer	0.000264	0.00599	CcSEcCtD
Mebendazole—Urticaria—Conjugated Estrogens—prostate cancer	0.000263	0.00596	CcSEcCtD
Mebendazole—Convulsion—Mitoxantrone—prostate cancer	0.000262	0.00594	CcSEcCtD
Mebendazole—Abdominal pain—Conjugated Estrogens—prostate cancer	0.000262	0.00593	CcSEcCtD
Mebendazole—Rash—Ethinyl Estradiol—prostate cancer	0.000256	0.00581	CcSEcCtD
Mebendazole—ABCB1—bone marrow—prostate cancer	0.000256	0.00905	CbGeAlD
Mebendazole—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000256	0.0058	CcSEcCtD
Mebendazole—Ketorolac—PTGS2—prostate cancer	0.000251	0.106	CrCbGaD
Mebendazole—Agranulocytosis—Docetaxel—prostate cancer	0.00025	0.00566	CcSEcCtD
Mebendazole—Hypersensitivity—Goserelin—prostate cancer	0.000246	0.00558	CcSEcCtD
Mebendazole—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000244	0.00553	CcSEcCtD
Mebendazole—Neutropenia—Prednisone—prostate cancer	0.000242	0.00549	CcSEcCtD
Mebendazole—Agranulocytosis—Capecitabine—prostate cancer	0.000242	0.00548	CcSEcCtD
Mebendazole—Hepatitis—Docetaxel—prostate cancer	0.00024	0.00545	CcSEcCtD
Mebendazole—Hepatitis—Capecitabine—prostate cancer	0.000233	0.00527	CcSEcCtD
Mebendazole—ABCB1—testis—prostate cancer	0.000219	0.00773	CbGeAlD
Mebendazole—Convulsion—Etoposide—prostate cancer	0.000218	0.00494	CcSEcCtD
Mebendazole—Gastrointestinal pain—Estradiol—prostate cancer	0.000217	0.00491	CcSEcCtD
Mebendazole—Rash—Goserelin—prostate cancer	0.000211	0.00478	CcSEcCtD
Mebendazole—Dermatitis—Goserelin—prostate cancer	0.000211	0.00477	CcSEcCtD
Mebendazole—Urticaria—Estradiol—prostate cancer	0.000211	0.00477	CcSEcCtD
Mebendazole—Abdominal pain—Estradiol—prostate cancer	0.00021	0.00475	CcSEcCtD
Mebendazole—Rash—Conjugated Estrogens—prostate cancer	0.000209	0.00473	CcSEcCtD
Mebendazole—Dermatitis—Conjugated Estrogens—prostate cancer	0.000209	0.00473	CcSEcCtD
Mebendazole—Tiaprofenic acid—PTGS2—prostate cancer	0.000205	0.0867	CrCbGaD
Mebendazole—Gastrointestinal pain—Mitoxantrone—prostate cancer	0.000202	0.00458	CcSEcCtD
Mebendazole—Urticaria—Mitoxantrone—prostate cancer	0.000196	0.00445	CcSEcCtD
Mebendazole—Hypersensitivity—Estradiol—prostate cancer	0.000195	0.00443	CcSEcCtD
Mebendazole—Abdominal pain—Mitoxantrone—prostate cancer	0.000195	0.00443	CcSEcCtD
Mebendazole—Nepafenac—PTGS2—prostate cancer	0.000195	0.0824	CrCbGaD
Mebendazole—Neutropenia—Epirubicin—prostate cancer	0.000189	0.00429	CcSEcCtD
Mebendazole—Hypersensitivity—Mitoxantrone—prostate cancer	0.000182	0.00412	CcSEcCtD
Mebendazole—Convulsion—Docetaxel—prostate cancer	0.000181	0.00411	CcSEcCtD
Mebendazole—Neutropenia—Doxorubicin—prostate cancer	0.000175	0.00397	CcSEcCtD
Mebendazole—Agranulocytosis—Epirubicin—prostate cancer	0.000169	0.00382	CcSEcCtD
Mebendazole—Gastrointestinal pain—Etoposide—prostate cancer	0.000168	0.00381	CcSEcCtD
Mebendazole—Rash—Estradiol—prostate cancer	0.000167	0.00379	CcSEcCtD
Mebendazole—Dermatitis—Estradiol—prostate cancer	0.000167	0.00378	CcSEcCtD
Mebendazole—Angioedema—Prednisone—prostate cancer	0.000165	0.00374	CcSEcCtD
Mebendazole—Urticaria—Etoposide—prostate cancer	0.000163	0.0037	CcSEcCtD
Mebendazole—Abdominal pain—Etoposide—prostate cancer	0.000162	0.00368	CcSEcCtD
Mebendazole—Hepatitis—Epirubicin—prostate cancer	0.000162	0.00367	CcSEcCtD
Mebendazole—ABCB1—lymph node—prostate cancer	0.000159	0.00561	CbGeAlD
Mebendazole—Convulsion—Prednisone—prostate cancer	0.000156	0.00354	CcSEcCtD
Mebendazole—Agranulocytosis—Doxorubicin—prostate cancer	0.000156	0.00353	CcSEcCtD
Mebendazole—Rash—Mitoxantrone—prostate cancer	0.000156	0.00353	CcSEcCtD
Mebendazole—Dermatitis—Mitoxantrone—prostate cancer	0.000156	0.00353	CcSEcCtD
Mebendazole—Hypersensitivity—Etoposide—prostate cancer	0.000151	0.00343	CcSEcCtD
Mebendazole—Hepatitis—Doxorubicin—prostate cancer	0.00015	0.0034	CcSEcCtD
Mebendazole—Gastrointestinal pain—Docetaxel—prostate cancer	0.00014	0.00316	CcSEcCtD
Mebendazole—Gastrointestinal pain—Capecitabine—prostate cancer	0.000135	0.00306	CcSEcCtD
Mebendazole—Abdominal pain—Docetaxel—prostate cancer	0.000135	0.00306	CcSEcCtD
Mebendazole—Urticaria—Capecitabine—prostate cancer	0.000131	0.00298	CcSEcCtD
Mebendazole—Abdominal pain—Capecitabine—prostate cancer	0.000131	0.00296	CcSEcCtD
Mebendazole—Rash—Etoposide—prostate cancer	0.00013	0.00294	CcSEcCtD
Mebendazole—Dermatitis—Etoposide—prostate cancer	0.000129	0.00293	CcSEcCtD
Mebendazole—Hypersensitivity—Docetaxel—prostate cancer	0.000126	0.00285	CcSEcCtD
Mebendazole—Convulsion—Epirubicin—prostate cancer	0.000122	0.00277	CcSEcCtD
Mebendazole—Hypersensitivity—Capecitabine—prostate cancer	0.000122	0.00276	CcSEcCtD
Mebendazole—Gastrointestinal pain—Prednisone—prostate cancer	0.00012	0.00273	CcSEcCtD
Mebendazole—Urticaria—Prednisone—prostate cancer	0.000117	0.00265	CcSEcCtD
Mebendazole—Abdominal pain—Prednisone—prostate cancer	0.000116	0.00264	CcSEcCtD
Mebendazole—Convulsion—Doxorubicin—prostate cancer	0.000113	0.00256	CcSEcCtD
Mebendazole—Hypersensitivity—Prednisone—prostate cancer	0.000108	0.00246	CcSEcCtD
Mebendazole—Rash—Docetaxel—prostate cancer	0.000108	0.00244	CcSEcCtD
Mebendazole—Dermatitis—Docetaxel—prostate cancer	0.000108	0.00244	CcSEcCtD
Mebendazole—Rash—Capecitabine—prostate cancer	0.000104	0.00236	CcSEcCtD
Mebendazole—Dermatitis—Capecitabine—prostate cancer	0.000104	0.00236	CcSEcCtD
Mebendazole—Gastrointestinal pain—Epirubicin—prostate cancer	9.42e-05	0.00213	CcSEcCtD
Mebendazole—Rash—Prednisone—prostate cancer	9.28e-05	0.0021	CcSEcCtD
Mebendazole—Dermatitis—Prednisone—prostate cancer	9.28e-05	0.0021	CcSEcCtD
Mebendazole—Urticaria—Epirubicin—prostate cancer	9.15e-05	0.00207	CcSEcCtD
Mebendazole—Abdominal pain—Epirubicin—prostate cancer	9.1e-05	0.00206	CcSEcCtD
Mebendazole—Gastrointestinal pain—Doxorubicin—prostate cancer	8.71e-05	0.00197	CcSEcCtD
Mebendazole—Hypersensitivity—Epirubicin—prostate cancer	8.49e-05	0.00192	CcSEcCtD
Mebendazole—Urticaria—Doxorubicin—prostate cancer	8.47e-05	0.00192	CcSEcCtD
Mebendazole—Abdominal pain—Doxorubicin—prostate cancer	8.42e-05	0.00191	CcSEcCtD
Mebendazole—Ketoprofen—PTGS2—prostate cancer	7.89e-05	0.0334	CrCbGaD
Mebendazole—Hypersensitivity—Doxorubicin—prostate cancer	7.85e-05	0.00178	CcSEcCtD
Mebendazole—Rash—Epirubicin—prostate cancer	7.26e-05	0.00165	CcSEcCtD
Mebendazole—Dermatitis—Epirubicin—prostate cancer	7.26e-05	0.00164	CcSEcCtD
Mebendazole—Rash—Doxorubicin—prostate cancer	6.72e-05	0.00152	CcSEcCtD
Mebendazole—Dermatitis—Doxorubicin—prostate cancer	6.71e-05	0.00152	CcSEcCtD
Mebendazole—ABCB1—Metabolism—ACSL4—prostate cancer	9.2e-06	0.000103	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD17B3—prostate cancer	9.2e-06	0.000103	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTA2—prostate cancer	9.15e-06	0.000102	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	9.12e-06	0.000102	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	9.1e-06	0.000102	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SULT1A1—prostate cancer	9.04e-06	0.000101	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ABCG5—prostate cancer	9.04e-06	0.000101	CbGpPWpGaD
Mebendazole—TUBB4B—Cell Cycle—TP53—prostate cancer	8.85e-06	9.91e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTA1—prostate cancer	8.83e-06	9.89e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PHGDH—prostate cancer	8.82e-06	9.88e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ARG2—prostate cancer	8.82e-06	9.88e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UMPS—prostate cancer	8.82e-06	9.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UGT2B15—prostate cancer	8.8e-06	9.85e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UGT2B17—prostate cancer	8.8e-06	9.85e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GRHPR—prostate cancer	8.8e-06	9.85e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CKMT2—prostate cancer	8.8e-06	9.85e-05	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—NCOA1—prostate cancer	8.77e-06	9.82e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NAT2—prostate cancer	8.73e-06	9.77e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HSD3B2—prostate cancer	8.73e-06	9.77e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTO1—prostate cancer	8.73e-06	9.77e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	8.68e-06	9.72e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LDHB—prostate cancer	8.65e-06	9.69e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP3A5—prostate cancer	8.49e-06	9.51e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	8.44e-06	9.45e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	8.39e-06	9.4e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PLCB2—prostate cancer	8.37e-06	9.37e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2C18—prostate cancer	8.37e-06	9.37e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LRP2—prostate cancer	8.37e-06	9.37e-05	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—RXRA—prostate cancer	8.34e-06	9.34e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SULT2B1—prostate cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RFK—prostate cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM3—prostate cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAGLU—prostate cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MBTPS1—prostate cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PGAM2—prostate cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AOX1—prostate cancer	8.27e-06	9.26e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	8.22e-06	9.21e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—P4HB—prostate cancer	8.21e-06	9.19e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PDHA1—prostate cancer	8.2e-06	9.18e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TCN2—prostate cancer	8.2e-06	9.18e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA3—prostate cancer	8.2e-06	9.18e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—UCP3—prostate cancer	8.2e-06	9.18e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC22A1—prostate cancer	7.98e-06	8.94e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	7.89e-06	8.84e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP3A43—prostate cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AMACR—prostate cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAT1—prostate cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—DEGS1—prostate cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SRD5A2—prostate cancer	7.84e-06	8.78e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD3B1—prostate cancer	7.82e-06	8.76e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC22A3—prostate cancer	7.82e-06	8.76e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SULT2A1—prostate cancer	7.78e-06	8.71e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MED12—prostate cancer	7.65e-06	8.57e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GNG5—prostate cancer	7.59e-06	8.5e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	7.57e-06	8.47e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	7.55e-06	8.45e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA4—prostate cancer	7.5e-06	8.4e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TBXAS1—prostate cancer	7.5e-06	8.4e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD17B1—prostate cancer	7.48e-06	8.37e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	7.4e-06	8.29e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOA3—prostate cancer	7.31e-06	8.19e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA2—prostate cancer	7.31e-06	8.18e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ABCG5—prostate cancer	7.22e-06	8.08e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SULT1A1—prostate cancer	7.22e-06	8.08e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	7.19e-06	8.05e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTA1—prostate cancer	7.05e-06	7.9e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	6.99e-06	7.83e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—HPGDS—prostate cancer	6.98e-06	7.81e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HSD3B2—prostate cancer	6.97e-06	7.81e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NAT2—prostate cancer	6.97e-06	7.81e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTO1—prostate cancer	6.97e-06	7.81e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2C19—prostate cancer	6.93e-06	7.77e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTT1—prostate cancer	6.77e-06	7.58e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ACHE—prostate cancer	6.77e-06	7.58e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2A6—prostate cancer	6.69e-06	7.49e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PLCB2—prostate cancer	6.68e-06	7.49e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LRP2—prostate cancer	6.68e-06	7.49e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2C18—prostate cancer	6.68e-06	7.49e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—B4GALT4—prostate cancer	6.67e-06	7.46e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HPGD—prostate cancer	6.67e-06	7.46e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	6.66e-06	7.46e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—P4HB—prostate cancer	6.55e-06	7.34e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKR1C3—prostate cancer	6.51e-06	7.29e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PRKACB—prostate cancer	6.47e-06	7.25e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	6.42e-06	7.19e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP17A1—prostate cancer	6.41e-06	7.17e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC22A1—prostate cancer	6.38e-06	7.14e-05	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—PPARA—prostate cancer	6.37e-06	7.14e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	6.32e-06	7.08e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TNFRSF21—prostate cancer	6.27e-06	7.02e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SULT2A1—prostate cancer	6.21e-06	6.96e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	6.21e-06	6.96e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MED12—prostate cancer	6.11e-06	6.85e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOA2—prostate cancer	6.1e-06	6.84e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP7B1—prostate cancer	6.1e-06	6.83e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTAP—prostate cancer	6.1e-06	6.83e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GNG5—prostate cancer	6.06e-06	6.79e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SULT1E1—prostate cancer	5.94e-06	6.65e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SRD5A1—prostate cancer	5.94e-06	6.65e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOA3—prostate cancer	5.84e-06	6.54e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—SLC5A5—prostate cancer	5.82e-06	6.52e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP2E1—prostate cancer	5.69e-06	6.37e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD17B3—prostate cancer	5.67e-06	6.35e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ACSL4—prostate cancer	5.67e-06	6.35e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NQO1—prostate cancer	5.62e-06	6.3e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—HPGDS—prostate cancer	5.57e-06	6.24e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TH—prostate cancer	5.54e-06	6.21e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2C19—prostate cancer	5.54e-06	6.2e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	5.51e-06	6.17e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP3A4—prostate cancer	5.49e-06	6.14e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	5.46e-06	6.11e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UMPS—prostate cancer	5.43e-06	6.09e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PHGDH—prostate cancer	5.43e-06	6.09e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ARG2—prostate cancer	5.43e-06	6.09e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ACHE—prostate cancer	5.41e-06	6.05e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTT1—prostate cancer	5.41e-06	6.05e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP1B1—prostate cancer	5.39e-06	6.04e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2A6—prostate cancer	5.34e-06	5.98e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LDHB—prostate cancer	5.33e-06	5.97e-05	CbGpPWpGaD
Mebendazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	5.25e-06	5.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP3A5—prostate cancer	5.23e-06	5.86e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GGT1—prostate cancer	5.22e-06	5.85e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKR1C3—prostate cancer	5.2e-06	5.82e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PRKACB—prostate cancer	5.17e-06	5.79e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NCOA1—prostate cancer	5.14e-06	5.76e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP17A1—prostate cancer	5.12e-06	5.73e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CYP19A1—prostate cancer	5.07e-06	5.68e-05	CbGpPWpGaD
Mebendazole—ABCB1—Transmembrane transport of small molecules—CREBBP—prostate cancer	5.06e-06	5.67e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PDHA1—prostate cancer	5.05e-06	5.66e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—UCP3—prostate cancer	5.05e-06	5.66e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA3—prostate cancer	5.05e-06	5.66e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TCN2—prostate cancer	5.05e-06	5.66e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—RXRA—prostate cancer	4.89e-06	5.48e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOA2—prostate cancer	4.88e-06	5.46e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC22A3—prostate cancer	4.82e-06	5.4e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD3B1—prostate cancer	4.82e-06	5.4e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	4.76e-06	5.33e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—COMT—prostate cancer	4.71e-06	5.28e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTP1—prostate cancer	4.69e-06	5.25e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—SLC5A5—prostate cancer	4.65e-06	5.21e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA4—prostate cancer	4.62e-06	5.17e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TBXAS1—prostate cancer	4.62e-06	5.17e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ITPR1—prostate cancer	4.62e-06	5.17e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP2E1—prostate cancer	4.54e-06	5.09e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	4.54e-06	5.08e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA2—prostate cancer	4.5e-06	5.04e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NQO1—prostate cancer	4.49e-06	5.03e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ABCG5—prostate cancer	4.45e-06	4.98e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SULT1A1—prostate cancer	4.45e-06	4.98e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TH—prostate cancer	4.43e-06	4.96e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP3A4—prostate cancer	4.38e-06	4.91e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—TYMS—prostate cancer	4.36e-06	4.88e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTA1—prostate cancer	4.34e-06	4.86e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—GSTM1—prostate cancer	4.31e-06	4.83e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1B1—prostate cancer	4.31e-06	4.82e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NAT2—prostate cancer	4.3e-06	4.81e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTO1—prostate cancer	4.3e-06	4.81e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HSD3B2—prostate cancer	4.3e-06	4.81e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—LPL—prostate cancer	4.23e-06	4.74e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GGT1—prostate cancer	4.17e-06	4.67e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PLCB2—prostate cancer	4.12e-06	4.61e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LRP2—prostate cancer	4.12e-06	4.61e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2C18—prostate cancer	4.12e-06	4.61e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NCOA1—prostate cancer	4.11e-06	4.6e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—ERCC2—prostate cancer	4.05e-06	4.54e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP19A1—prostate cancer	4.05e-06	4.53e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—P4HB—prostate cancer	4.04e-06	4.52e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC22A1—prostate cancer	3.93e-06	4.4e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—RXRA—prostate cancer	3.91e-06	4.38e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SULT2A1—prostate cancer	3.83e-06	4.29e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—MTHFR—prostate cancer	3.81e-06	4.27e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MED12—prostate cancer	3.77e-06	4.22e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—COMT—prostate cancer	3.76e-06	4.22e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTP1—prostate cancer	3.75e-06	4.2e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PPARA—prostate cancer	3.74e-06	4.19e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GNG5—prostate cancer	3.74e-06	4.18e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ITPR1—prostate cancer	3.69e-06	4.13e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOA3—prostate cancer	3.6e-06	4.03e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CAV1—prostate cancer	3.51e-06	3.94e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—TYMS—prostate cancer	3.48e-06	3.9e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—GSTM1—prostate cancer	3.44e-06	3.86e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—HPGDS—prostate cancer	3.43e-06	3.85e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2C19—prostate cancer	3.41e-06	3.82e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—LPL—prostate cancer	3.38e-06	3.78e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	3.36e-06	3.76e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTT1—prostate cancer	3.33e-06	3.73e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ACHE—prostate cancer	3.33e-06	3.73e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2A6—prostate cancer	3.29e-06	3.69e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CYP1A1—prostate cancer	3.26e-06	3.66e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—ERCC2—prostate cancer	3.24e-06	3.63e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKR1C3—prostate cancer	3.2e-06	3.59e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CG—prostate cancer	3.2e-06	3.58e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PRKACB—prostate cancer	3.19e-06	3.57e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP17A1—prostate cancer	3.15e-06	3.53e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—MTHFR—prostate cancer	3.04e-06	3.41e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—INS—prostate cancer	3.03e-06	3.39e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOA2—prostate cancer	3e-06	3.36e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PPARA—prostate cancer	2.99e-06	3.34e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—CREBBP—prostate cancer	2.97e-06	3.32e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—SLC5A5—prostate cancer	2.87e-06	3.21e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CD—prostate cancer	2.81e-06	3.15e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CAV1—prostate cancer	2.81e-06	3.14e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP2E1—prostate cancer	2.8e-06	3.13e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NQO1—prostate cancer	2.77e-06	3.1e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TH—prostate cancer	2.73e-06	3.05e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—NOS3—prostate cancer	2.66e-06	2.98e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1B1—prostate cancer	2.65e-06	2.97e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GGT1—prostate cancer	2.57e-06	2.88e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CG—prostate cancer	2.56e-06	2.86e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NCOA1—prostate cancer	2.53e-06	2.83e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP19A1—prostate cancer	2.49e-06	2.79e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CB—prostate cancer	2.45e-06	2.75e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTGS2—prostate cancer	2.43e-06	2.72e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—INS—prostate cancer	2.42e-06	2.71e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—RXRA—prostate cancer	2.41e-06	2.7e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—CREBBP—prostate cancer	2.37e-06	2.65e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—COMT—prostate cancer	2.32e-06	2.6e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTP1—prostate cancer	2.31e-06	2.59e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ITPR1—prostate cancer	2.27e-06	2.54e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CD—prostate cancer	2.25e-06	2.52e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—TYMS—prostate cancer	2.15e-06	2.4e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—NOS3—prostate cancer	2.12e-06	2.38e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—GSTM1—prostate cancer	2.12e-06	2.38e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PTEN—prostate cancer	2.12e-06	2.37e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—LPL—prostate cancer	2.08e-06	2.33e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—EP300—prostate cancer	2.02e-06	2.26e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.01e-06	2.25e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—ERCC2—prostate cancer	1.99e-06	2.23e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CB—prostate cancer	1.96e-06	2.19e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTGS2—prostate cancer	1.94e-06	2.17e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—MTHFR—prostate cancer	1.87e-06	2.1e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PPARA—prostate cancer	1.84e-06	2.06e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CAV1—prostate cancer	1.73e-06	1.94e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PTEN—prostate cancer	1.69e-06	1.9e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—EP300—prostate cancer	1.61e-06	1.81e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.58e-06	1.76e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—PIK3CA—prostate cancer	1.5e-06	1.67e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—INS—prostate cancer	1.49e-06	1.67e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—CREBBP—prostate cancer	1.46e-06	1.64e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.38e-06	1.55e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—NOS3—prostate cancer	1.31e-06	1.46e-05	CbGpPWpGaD
Mebendazole—CYP1A1—Metabolism—AKT1—prostate cancer	1.22e-06	1.37e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.21e-06	1.35e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTGS2—prostate cancer	1.2e-06	1.34e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—PIK3CA—prostate cancer	1.19e-06	1.34e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PTEN—prostate cancer	1.04e-06	1.17e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—EP300—prostate cancer	9.95e-07	1.11e-05	CbGpPWpGaD
Mebendazole—ABCB1—Metabolism—AKT1—prostate cancer	9.76e-07	1.09e-05	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—PIK3CA—prostate cancer	7.36e-07	8.24e-06	CbGpPWpGaD
Mebendazole—CYP3A4—Metabolism—AKT1—prostate cancer	6.01e-07	6.73e-06	CbGpPWpGaD
